iX Biopharma Ltd. announced that on Feb, 06 2026 it allotted and issued 20,000 new ordinary shares after holders exercised warrants at 0.06 Singapore dollars per share.
The issuance increases the company’s total share count from 959,424,245 to 959,444,245. The new shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on or around Feb, 10 2026.
To date, 4,484,800 warrants—about 7.80% of those originally issued—have been exercised. A balance of 53,024,679 warrants remains outstanding, each with an exercise price of 0.06 Singapore dollars and an expiry date of Jul, 18 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.